U.S. market Closed. Opens in 3 hours 35 minutes

PBYI | Puma Biotechnology, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Revenue235.64M228.00M253.20M225.10M272.30M251.00M27.70MN/AN/AN/AN/AN/A-281.10KN/AN/AN/AN/A
Cost of Revenue62.68M55.10M63.70M39.40M36.80M34.60M5.60M1.15M776.00KN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit172.96M172.90M189.50M185.70M235.50M216.40M22.10M-1.15M-776.00KN/AN/AN/A-281.10KN/AN/AN/AN/A
Operating Expenses140.31M142.20M188.20M216.10M274.60M311.10M314.50M276.60M240.30M142.30M54.83M74.40M10.16M15.98K16.84K14.08K-15.09M
Selling, General & Admin89.31M90.00M116.30M118.40M141.70M146.20M106.70M53.80M31.80M19.40M9.79M24.80M9.32M15.98K16.84K14.08KN/A
Research & Development50.38M52.20M71.90M97.70M132.90M164.90M207.80M222.80M208.50M122.90M45.05M49.60M826.37KN/AN/AN/AN/A
Other Operating Expenses625.00K-28.00K300.00K400.00K200.00K-9.70M-100.00K-400.00K25.00K-14.00K2.00K293.00K10.70KN/AN/AN/A-15.09M
Operating Income32.64M23.70M-8.90M-30.40M-39.10M-94.70M-292.40M-276.60M-240.30M-142.30M-54.83M-74.40M-10.16M-15.98K-16.84K-14.08K-15.09M
Other Expenses / Income-9.97M-23.26M-30.09M-29.39M53.00K-18.92M435.00K585.00K996.00K310.00K174.00K98.00K-76.22KN/AN/AN/AN/A
Before Tax Income22.67M500.00K-28.80M-59.80M-75.60M-113.60M-292.00M-276.00M-239.30M-142.00M-54.66M-74.30M-10.23M-15.98K-16.84K-14.08K-15.09M
Income Tax Expenses1.08M500.00K300.00K200.00K7.12M-7.92M-2.21M-2.15M-1.75M-941.00K-172.00K-267.00K76.22KN/AN/AN/AN/A
Net Income21.59M912.00K-29.10M-60.00M-82.72M-113.60M-292.00M-276.00M-239.30M-142.00M-54.66M-74.30M-10.23M-15.98K-16.84K-14.08K-15.09M
Interest Expenses13.33M11.50M12.80M14.10M15.00M11.00M700.00K958.00K971.00K324.00K172.00K98.00K3.78KN/AN/AN/AN/A
Basic Shares Outstanding47.13M44.67M40.64M39.58M38.77M37.94M37.17M33.30M32.13M30.01M28.70M21.73M20.04M7.75M3.00M3.00M39.29M
Diluted Shares Outstanding47.55M44.93M40.64M39.58M38.77M37.94M37.17M33.30M32.13M30.01M28.70M21.73M20.04M7.75M3.00M3.00M39.29M
EBITDA47.52M20.97M-5.40M-38.54M-55.72M-95.21M-288.42M-275.45M-239.50M-141.65M-54.41M-74.09M-10.22M-15.98K-16.84K-14.08K-15.09M
EBITDA Margin20.17%9.20%-2.13%-17.12%-20.46%-37.93%-1,041.24%0.00%0.00%0.00%0.00%0.00%3,636.54%0.00%0.00%0.00%0.00%
EBIT36.00M12.91M-16.00M-45.70M-60.60M-110.52M-293.51M-277.19M-240.08M-142.62M-54.66M-74.47M-10.15M-15.98K-16.84K-14.08K-15.09M
EBIT Margin15.28%5.66%-6.32%-20.30%-22.25%-44.03%-1,059.61%0.00%0.00%0.00%0.00%0.00%3,611.89%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙